SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000906344-00-000002
Filing Date
2000-01-06
Accepted
2000-01-06 00:00:00
Documents
1
Group Members
YAMANOUCHI GROUP HOLDING, INC.YAMANOUCHI PHARMACEUTICAL CO LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 9259
  Complete submission text file 0000906344-00-000002.txt   11129
Mailing Address 311 NIHONBASHI HONCHO 2 CHOME CHUO-KU TOKYO JAPAN M0
Business Address 311 NILHONBASHI HONCHO 2 CHOME CHUO-KU TOKOYO 103 JAPAN
YAMANOUCHI PHARMACEUTICAL CO LTD (Filed by) CIK: 0000905462 (see all company filings)

 

Mailing Address EAST ANTON ANDOVER HAMPSHIRE ENGLAND ENGLAND SP10 5RG
Business Address EAST ANTON ANDOVER HAMPSHIRE ENGLAND ENGLAND SP10 5RG
SHIRE PHARMACEUTICALS GROUP PLC (Subject) CIK: 0000936402 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-55755 | Film No.: 502629
SIC: 2834 Pharmaceutical Preparations